The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment

Recruiting · NCT05655780 · Registry updated 2025-05-18

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Recruiting	Not stated	2025-05-18		NCT05655780

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	199
Catharina Ziekenhuis	1
Clinical Trial Center Maastricht B.V.	1
CRC-guideline committee	1
CZ zorgverzekeraar	1
Danone Nutricia Research	2
Dutch Colorectal Cancer Group	5
Erasmus Medical Center	271
Fontys Hogeschool	1
Gelderse Vallei Hospital	11
Landelijke Werkgroep Diëtisten Oncologie (LWDO)	1
Maastricht University	40
Maastricht University Medical Center	157
Oncology patientenpanel MUMC	1
Prospectief Landelijk CRC Cohort (PLCRC)	2
Rode Kruis Ziekenhuis Beverwijk	2
Stichting Kanker.nl	1
University of North Carolina	30
Van Weel-Bethesda Ziekenhuis	1
VieCuri Medisch Centrum voor Noord-Limburg	1
Wageningen University & Research	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Maastricht UMC+	Maastricht	Netherlands	13

Clinical trials